Renova Therapeutics Raises $7.52M
NOVEMBER 18, 2014
San Diego-based Renova Therapeutics , a biopharmaceuticals company developing treatments for congestive heart failure and other diseases, has raised $7.52M in a Series C funding round. The company said the funding primarily came from high net worth individuals. As part of the funding, Daniel M. Bradbury has joined the company''s board.